Particle.news

Download on the App Store

Serena Williams Partners With Ro, Reveals GLP‑1 Use as Online Criticism Mounts

Critics question the message’s impact on young audiences, raising concerns about medicalized postpartum weight loss.

Image
Image
Image
Image

Overview

  • Ro and Williams announced a paid partnership in a joint Instagram post that showed the 23‑time Grand Slam winner administering a weekly GLP‑1 injection.
  • Williams told People she has lost more than 30 pounds, saying she feels healthy and that injections began in August 2023 after prolonged postpartum weight struggles.
  • Comments on the post condemned the message as “very dangerous for society,” with some saying it sends a “terrible message to our youth,” particularly young female athletes.
  • Outlets reporting on the reaction noted they sought comment from Williams’ representatives and did not receive an immediate response.
  • An opinion piece in The Independent framed the deal as a cultural shift toward normalizing prescription weight‑loss drugs and questioned the broader implications for body image.